ACG and CCFA Co-Hosted an IBD Circle Webinar
Optimizing Medical Therapy in IBD:
Enter the Biosimilars
June 29, 2016
You can listen this webinar with David T. Rubin, MD, FACG who shares insights on how clinicians can best use the currently available medical therapies in IBD. With biosimilars on the horizon, Dr. Rubin touched on some of the potential issues related to these new therapeutic options.
This webinar was offered through the ACG-CCFA IBD Circle, a private online community for members of ACG and CCFA. Login required to listen to the webinar and join the discussion on the ACG-CCFA IBD Circle.
Presenter: David T. Rubin, MD, FACG
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Co-Director, Digestive Diseases Center
The University of Chicago Medicine
Dr. Rubin specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) and high-risk cancer syndromes.
Dr. Rubin performs clinical research related to outcomes in inflammatory bowel diseases, with particular interest in prevention of cancer associated with these diseases. He is also interested in new therapies for inflammatory bowel diseases and better screening tools for colorectal cancer.
Follow Dr. Rubin on Twitter @IBDMD